FDA sued for failing to act on painkiller

A consumer group has sued the FDA, saying the agency has been too slow in acting against the painkiller known as Darvon, a.k.a. propoxyphene. In its suit, Public Citizen says FDA broke the law by not ruling on its petition against drug, which it filed two years ago. The agency was required to act on it within six months, the suit says. Report

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.